Agilent Technologies, Inc. (A) vs Quest Diagnostics Incorporated (DGX)
- Agilent Technologies, Inc. A 171.89 −2.98%
- Quest Diagnostics Incorporated DGX 254.25 −0.56%
Agilent Technologies, Inc. and Quest Diagnostics Incorporated are both Diagnostics & Research companies. Agilent Technologies, Inc. is the larger, with a market value of $48.4B against $28.0B — 1.7× the size. Quest Diagnostics Incorporated trades at the lower P/E: 25.0× against 33.8×. Quest Diagnostics Incorporated grew revenue faster over the last twelve months: 9.13% against 8.60%. Agilent Technologies, Inc. has the higher net margin (19.5% vs 9.50%) and the higher return on invested capital (11.1% vs 8.48%). Both pay a dividend; Quest Diagnostics Incorporated yields more (1.33% vs 0.59%). Across the 23 metrics below, Agilent Technologies, Inc. leads on 12 and Quest Diagnostics Incorporated on 11.
Valuation
Profitability
| Metric | A | DGX | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 53.83% | 33.11% | 48.32% |
| Operating margin | 22.23% | 14.55% | (5.68%) |
| Net margin | 19.53% | 9.50% | (4.10%) |
| Free cash flow margin | 17.19% | 11.61% | 0.00% |
| Return on equity | 20.97% | 14.76% | 0.00% |
| Return on assets | 11.00% | 6.73% | (6.05%) |
| Return on invested capital | 11.07% | 8.48% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack